2011
DOI: 10.1002/mus.22124
|View full text |Cite
|
Sign up to set email alerts
|

The struggle to model muscular dystrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
(40 reference statements)
0
1
0
Order By: Relevance
“…1) and plays a pivotal role not only in transferring the contraction force from the contractile apparatus to the ECM, but also in cell signalling, membrane stabilization and Ca 2+ influx (Markert et al, 2011). Despite the detailed knowledge available on dystrophin function, no resolutive cure has been developed, partially due to the fact that dystrophin-deficient mice fail to recapitulate the clinical severity of DMD in humans (Hoffman et al, 1987; Kang, 2011). Current management of DMD is mainly based on administration of corticosteroids, which slow disease progression but do not constitute a cure.…”
Section: Modelling Dmd and Bmdmentioning
confidence: 99%
“…1) and plays a pivotal role not only in transferring the contraction force from the contractile apparatus to the ECM, but also in cell signalling, membrane stabilization and Ca 2+ influx (Markert et al, 2011). Despite the detailed knowledge available on dystrophin function, no resolutive cure has been developed, partially due to the fact that dystrophin-deficient mice fail to recapitulate the clinical severity of DMD in humans (Hoffman et al, 1987; Kang, 2011). Current management of DMD is mainly based on administration of corticosteroids, which slow disease progression but do not constitute a cure.…”
Section: Modelling Dmd and Bmdmentioning
confidence: 99%